Analysis by outcome
Analysis by both treatment arm and the primary study outcome (EmCS) also
demonstrated the cost-saving associated with CTG+STan was present in
both EmCS and non-EmCS cases, but with the finding more strongly
represented in the mothers and babies who did not experience EmCS
(Supplementary table 3).